Adaptive Biotechnologies (ADPT) Goodwill & Intangibles (2018 - 2026)

Adaptive Biotechnologies has disclosed Goodwill & Intangibles across 9 years of filings, most recently posting $119.9 million for Q2 2026.

• In Q2 2026, Goodwill & Intangibles fell 1.4% year-over-year to $119.9 million; the TTM figure through Jun 2026 stood at $119.9 million (down 1.4% YoY), while the FY2025 annual figure was $120.7 million, down 13.35% from the prior year.
• Goodwill & Intangibles came in at $119.9 million for Q2 2026 at Adaptive Biotechnologies, roughly flat from $120.3 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $139.3 million in Q1 2022 to a low of $119.9 million in Q2 2026.
• Average Goodwill & Intangibles over 5 years is $128.1 million, with a median of $124.1 million recorded in 2023.
• Year-over-year, Goodwill & Intangibles changed 0.0% in 2022 and retreated 13.35% in 2025.
• Over 5 years, Goodwill & Intangibles stood at $139.3 million in 2022, then changed by 0.0% to $139.3 million in 2023, then changed by 0.0% to $139.3 million in 2024, then dropped by 13.35% to $120.7 million in 2025, then retreated by 0.7% to $119.9 million in 2026.
• Per Business Quant data, the three most recent Goodwill & Intangibles figures were $119.9 million in Q2 2026, $120.3 million in Q1 2026, and $120.7 million in Q4 2025.